vs

Side-by-side financial comparison of Carter Bankshares, Inc. (CARE) and Talkspace, Inc. (TALK). Click either name above to swap in a different company.

Talkspace, Inc. is the larger business by last-quarter revenue ($63.0M vs $39.8M, roughly 1.6× Carter Bankshares, Inc.). On growth, Talkspace, Inc. posted the faster year-over-year revenue change (29.3% vs 15.4%). Over the past eight quarters, Talkspace, Inc.'s revenue compounded faster (17.8% CAGR vs 9.1%).

Carter Bankshares, Inc. is a U.S. regional bank holding company operating Carter Bank & Trust, a community-focused financial institution. It offers a full range of retail and commercial banking products including deposit accounts, personal and business loans, and wealth management services, primarily serving consumers and small business clients across Virginia and North Carolina.

Talkspace, Inc. is an American company that provides online and mobile therapy services. Founded in 2012 by Oren and Roni Frank, Talkspace connects users with licensed therapists and psychiatrists through web and mobile platforms. The service offers communication through text, audio, and video messaging, as well as live video sessions in some cases. The company is headquartered in New York City.

CARE vs TALK — Head-to-Head

Bigger by revenue
TALK
TALK
1.6× larger
TALK
$63.0M
$39.8M
CARE
Growing faster (revenue YoY)
TALK
TALK
+13.9% gap
TALK
29.3%
15.4%
CARE
Faster 2-yr revenue CAGR
TALK
TALK
Annualised
TALK
17.8%
9.1%
CARE

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
CARE
CARE
TALK
TALK
Revenue
$39.8M
$63.0M
Net Profit
$4.8M
Gross Margin
Operating Margin
27.8%
6.1%
Net Margin
7.6%
Revenue YoY
15.4%
29.3%
Net Profit YoY
292.5%
EPS (diluted)
$0.38

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
CARE
CARE
TALK
TALK
Q4 25
$39.8M
$63.0M
Q3 25
$39.1M
$59.4M
Q2 25
$37.3M
$54.3M
Q1 25
$37.0M
$52.2M
Q4 24
$34.5M
$48.7M
Q3 24
$34.2M
$47.4M
Q2 24
$33.6M
$46.1M
Q1 24
$33.5M
$45.4M
Net Profit
CARE
CARE
TALK
TALK
Q4 25
$4.8M
Q3 25
$5.4M
$3.3M
Q2 25
$8.5M
$-541.0K
Q1 25
$9.0M
$318.0K
Q4 24
$1.2M
Q3 24
$5.6M
$1.9M
Q2 24
$4.8M
$-474.0K
Q1 24
$5.8M
$-1.5M
Gross Margin
CARE
CARE
TALK
TALK
Q4 25
Q3 25
Q2 25
Q1 25
44.6%
Q4 24
44.2%
Q3 24
45.6%
Q2 24
45.5%
Q1 24
47.8%
Operating Margin
CARE
CARE
TALK
TALK
Q4 25
27.8%
6.1%
Q3 25
18.3%
3.7%
Q2 25
28.5%
-3.3%
Q1 25
30.1%
-2.1%
Q4 24
31.0%
1.2%
Q3 24
20.5%
0.2%
Q2 24
17.6%
-7.6%
Q1 24
21.6%
-3.7%
Net Margin
CARE
CARE
TALK
TALK
Q4 25
7.6%
Q3 25
13.9%
5.5%
Q2 25
22.8%
-1.0%
Q1 25
24.2%
0.6%
Q4 24
2.5%
Q3 24
16.4%
4.0%
Q2 24
14.3%
-1.0%
Q1 24
17.4%
-3.2%
EPS (diluted)
CARE
CARE
TALK
TALK
Q4 25
$0.38
Q3 25
$0.24
$0.02
Q2 25
$0.37
Q1 25
$0.39
$0.00
Q4 24
$0.36
$0.01
Q3 24
$0.24
$0.01
Q2 24
$0.21
$0.00
Q1 24
$0.25
$-0.01

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
CARE
CARE
TALK
TALK
Cash + ST InvestmentsLiquidity on hand
$37.4M
Total DebtLower is stronger
Stockholders' EquityBook value
$419.7M
$117.0M
Total Assets
$4.9B
$134.9M
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
CARE
CARE
TALK
TALK
Q4 25
$37.4M
Q3 25
$39.5M
Q2 25
$54.3M
Q1 25
$60.1M
Q4 24
$76.7M
Q3 24
$119.0M
Q2 24
$114.9M
Q1 24
$120.3M
Stockholders' Equity
CARE
CARE
TALK
TALK
Q4 25
$419.7M
$117.0M
Q3 25
$412.8M
$109.1M
Q2 25
$405.6M
$112.9M
Q1 25
$401.8M
$113.4M
Q4 24
$384.3M
$117.4M
Q3 24
$386.8M
$117.6M
Q2 24
$364.4M
$114.0M
Q1 24
$359.1M
$119.6M
Total Assets
CARE
CARE
TALK
TALK
Q4 25
$4.9B
$134.9M
Q3 25
$4.8B
$129.1M
Q2 25
$4.8B
$132.8M
Q1 25
$4.7B
$134.2M
Q4 24
$4.7B
$138.7M
Q3 24
$4.6B
$138.2M
Q2 24
$4.5B
$133.8M
Q1 24
$4.6B
$138.3M

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
CARE
CARE
TALK
TALK
Operating Cash FlowLast quarter
$39.9M
$5.4M
Free Cash FlowOCF − Capex
$31.8M
FCF MarginFCF / Revenue
79.9%
Capex IntensityCapex / Revenue
20.2%
Cash ConversionOCF / Net Profit
1.13×
TTM Free Cash FlowTrailing 4 quarters
$54.6M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
CARE
CARE
TALK
TALK
Q4 25
$39.9M
$5.4M
Q3 25
$11.8M
$4.7M
Q2 25
$9.6M
$-351.0K
Q1 25
$6.4M
$-1.2M
Q4 24
$36.9M
$3.7M
Q3 24
$10.3M
$6.2M
Q2 24
$-2.5M
$4.8M
Q1 24
$17.6M
$-3.4M
Free Cash Flow
CARE
CARE
TALK
TALK
Q4 25
$31.8M
Q3 25
$10.3M
Q2 25
$7.7M
Q1 25
$4.9M
Q4 24
$28.8M
Q3 24
$8.4M
Q2 24
$-4.3M
$4.5M
Q1 24
$16.3M
$-3.8M
FCF Margin
CARE
CARE
TALK
TALK
Q4 25
79.9%
Q3 25
26.3%
Q2 25
20.6%
Q1 25
13.1%
Q4 24
83.5%
Q3 24
24.6%
Q2 24
-12.7%
9.7%
Q1 24
48.8%
-8.3%
Capex Intensity
CARE
CARE
TALK
TALK
Q4 25
20.2%
Q3 25
3.9%
Q2 25
5.1%
Q1 25
4.1%
Q4 24
23.6%
Q3 24
5.5%
Q2 24
5.4%
0.7%
Q1 24
3.9%
0.8%
Cash Conversion
CARE
CARE
TALK
TALK
Q4 25
1.13×
Q3 25
2.18×
1.46×
Q2 25
1.13×
Q1 25
0.71×
-3.90×
Q4 24
3.02×
Q3 24
1.83×
3.31×
Q2 24
-0.51×
Q1 24
3.03×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

CARE
CARE

Segment breakdown not available.

TALK
TALK

Payor Revenue$47.7M76%
Dte Revenue$11.6M18%
Consumer$3.7M6%

Related Comparisons